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INTRODUCTION
Gastrointestinal tract is always associated with food,
sometimes allergen and toxin; therefore eosinophil is
naturally found in gastrointestinal tract. Esophagus is
a unique part of gastrointestinal tract. Normally, there
is no eosinophil found in esophagus. Some condition
may cause eosinophil infiltration in esophagus, such as
GERD, parasite infection, systemic eosinophilic
syndrome, and a condition which is recently called as
eosinophilic esophagitis.1-3
Eosinophilic esophagitis (EE) was first reported by
Landres et al on 1978, after that there was an
absent until in the mid-90’s.4 Since its clinical
manifestation becomes more familiar to the gastro-
enterologists and allergists; EE has become important
differential diagnosis for patients with esophageal
symptoms. Consequently, there is greater amount of
publication associated with EE and correlated to
eosinophilic gastroenteritis, i.e. a condition, which has
been known as a disease, associated with eosinophil
and gastrointestinal tract.3,4 Children and adults may
be affected by EE. As a disease entity, EE may
become diagnostic and therapeutic consideration, and
may become a challenge either for pediatric
gastroenterologist or common gastroenterologist.1-3
EPIDEMIOLOGY
Epidemiologic data of EE has not been sufficient,
because there is no consensus on EE, either about
diagnosis criteria or treatment. Most of publications
are case reports. It frequently occurs on children rather
than adults, with incidence estimation in children and
adults of 43/105 and 2.5/105 respectively.
EE predominantly occurs in male than female.2,5 6,7
PATHOPHYSIOLOGY
Based on its clinical manifestation and
immunologic characteristics, EE may be considered as
‘asthma of the esophagus’.1 Histological examination
reveals a lot of eosinophils infiltration on the whole
esophagus mucosa.1-3,5-8
Eosinophil derives from bone marrow and only
a little amount of it appears in peripheral blood
circulation. In a healthy person, it exists on lamina
 propria of gastrointestinal tract, except esophagus.
Normal esophagus has no eosinophil infiltration. If there
is eosinophil accumulation in esophagus, it indicates that
there is a disease problem.2,3,9
Eosinophils in gastrointestinal tract will increase if
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Eosinophilic Esophagitis 
inflammation occurs.3 Inflammation will cause 
eosinophils to infiltrate various organs such as lungs,  
esophagus, gastrointestinal tract and skin and it may  
have a role in organ damage and organ dysfunction.3  
 Hypothesis of food-induced EE is supported by  
observations of clinical symptoms and histological  
features in patients with EE who have been treated  
with diet therapy (food restriction and elemental diet  
supplement).2,5,10 Observations on experimental animal  
have been conducted and these support that  
aeroallergen does induce esophageal and lungs  
inflammation through mechanism of cytokines.10,11,12  
 Induced eosinophils in esophagus and its increasing  
activity are caused by IL-5, eotaxin, II-13 and II-14.  
In EE, Th2 response and IL-5 production, the key of  
eosinophils congregation, in rats with less IL-5  
receptor, significantly shows decreased eosinophils in  
gastrointestinal tract. Eotaxin in gastrointestinal tract  
has chemotaxis character.4 It has been known that  
 IL-4 and IL-13 may induce ‘eosinophil-specific  
eotaxin’ chemokines (eotaxin-1, eotaxin-2 and  
eotaxin-3). Its role has not been clear yet because we  
cannot  show  that  in  EE  there  is  eotaxin  
overproduction; whereas decreased eotaxin-1 in rats  
only brings about moderate experimental EE. Gene that  
codes eosinophils chemo- attractant specified for  
eotaxin-3 (known as CCL 26) is the most induced gene  
in patients with EE. Rats with receptor eotaxin-3  
deficiency were protected in experimental EE. These  
results supported the role of eotaxin-3 in  
the pathogenesis of EE disease, and EE is considered  
as a disease with important gene role.11,13  
 IL-13 is a pro-fibrotic cytokine, which is also  
produced by eosinophil. IL-13 in trachea may induce  
EE  associated  with  lungs  and  esophageal  
inflammation. IL-13 appears to be a serologic  
indicator of systemic inflammation. IL-13 induced EE  
and depends on the presence of IL-5, eotaxin and  
STAT-6.2 
Cysteinyl leukotrienes (CysLT) is an eosinophil  
chemo-attractant. The CysLT level of esophagus  
mucosa biopsy in children with AEE (Allergic  
Eosinophilic Esophagitis) is approximately similar to  
normal children and it does not depend on  
inflammation severity. We should consider  
the associated AEE treatment and CysLT antagonist.  
We need further investigation on CysLT receptor.14  
 Inflammation process may continue to chronic  
inflammation, which cause irreversible alteration on  
mucosa structure and elasticity as well as fibrosis in  
sub epithelial layer.2 
 
DIAGNOSIS 
The diagnosis of EE is based on patient’s clinical  
manifestation, endoscopic and radiographic profile as 
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well as histopathological criteria.2,5 EE may affect 
children, mostly in 7-10 years old, and in adults  
between 30-40 years old. EE is predominant in male  
than female. Dysphagia symptom is frequently found  
in adult EE, while in children it usually manifest as  
abdominal pain. Other symptoms and signs are showed  
in table 1.2,8 In children, it usually associated with  
history of allergic disorder, such as rhino- 
conjunctivitis, asthma, food allergy, eczema, or atopic  
dermatitis.2,12 
RADIOLOGY 
Radiographic examination for EE includes barium 
imaging. Most patient with idiopathic EE show 
indentation image, which appears as multiple rings, 
stricture, esophagitis.11 It may also indicate hiatus 
hernia and demonstrate a reflux (see figure 1).2 
Figure 1. Single-contrast esophagogram (RAO view, patient was 
prone) indicates esophagus profile caused by eosinophilic 
esophagitis.11 
ENDOSCOPY 
A thorough endoscopic observation will reveal  
abnormality in most of EE patients (~90%).1  
The abnormality may appear as a ring-like image in  
esophagus or a concentric ring image in esophagus 
49  
Table 1. Clinical features of eosinophilic esophagitis 2 
 Adult Pediatric 
Common Dysphagia 
Food impaction/foreign body 
Esophageal stricture 
Nausea/vomiting/regurgitation 
Heartburn 
Food allergy 
Abdominal pain 
Failure to thrive 
Nausea/vomiting 
Dysphagia 
Food allergy 
Heartburn 
Uncommon Hematemesis 
Globus 
Water brash 
Weight loss 
Chest pain 
Abdominal pain 
Food impaction 
Associated 
conditions 
History of atopy 
Asthma 
Allergic rhinitis 
Asthma 
Allergic rhinitis 
Eczema 
Atopic dermatitis 
Strong family 
history of atopy 
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(ringed esophagus), small esophagus caliber, with 
narrow internal diameter of esophagus, with or  
without stenosis in proximal esophagus (figure 2),6 or  
appearing like stricture.5-9,15 There is also ‘multipel web’  
or ‘corrugated ringed esophagus. Some authors detect  
a congenital stenosis esophagus, but it is often  
associated  with  EE.  It  is  different  from  
the Skatzki ring, which only has a single web in distal  
esophagus.16 A vertical line may also found in  
esophagus.2,6,7 
Sometimes, there is white exudates, vesicles or 
papule together with disappearing vascular image, 
which characterize the area of eosinophils infiltration 
(figure 2).6 The esophageal mucosa membrane may 
become fragile, which is called as ‘crêpe paper 
mucosa’.2,6,7 Therefore, the mucosa is easily torn when 
we perform dilatation treatment.2 A small sum of EE 
shows normal endoscopic profile.2,17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Endoscopic photographs showing common features of 
eosinophilic esophagitis7 
A. Concentric mucosal rings seen throughout the length of  
 the esophagus in a patient presenting with a food impaction.  
B.  Linear furrows or creases in the esophageal mucosa. 
C.  White exudates/plaques seen in some patients, which  
 correspond to areas of eosinophilic abscess eruption through  
 the esophageal mucosa. 
D.  Endoscopic photo of a patient with concentric mucosal rings  
 and small caliber esophagus. 
ULTRASONOGRAPH ENDOSCOPY 
It is rarely performed to establish the diagnosis of  
EE. It is performed when there is a circumferential  
profile and asymmetric thickening in muscle layers.2 
 
LABORATORY FINDINGS 
Specific laboratory findings in patients with EE have  
not been reported, therefore the sensitivity and 
specificity of laboratory test has not been known yet. 
Eosinophilia in peripheral blood circulation may occur  
in 5%-50% adult EE patients. Increased IgE serum,  
positive ‘skin prick’ test or radioallergosorbent test  
(RAST) may be found in 40%-73% pasien.2,12 Skin  
prick test and patch tests may identify the potential  
food, which may have important role in EE  
pathogenesis.17 
Figure 3. Pathological findings of esophagus mucosa in EE (A) 
Thickening of basal zone and intercellular edema (B) A lot of 
intraepithelial eosinophils (H&E staining).1 
HISTOLOGICAL FINDINGS 
Biopsy is recommended on proximal and distal 
esophagus. If endoscopic findings reveals white 
papule feature, then biopsy should be performed on 
that area, because it is the place where eosinophil 
congregated. 1,2,8 
The main histological findings in EE include  
eosinophil infiltration in esophagus. Hyperplasia in basal  
lamina and increased papillary size are not specific for  
EE. There is also increased eosinophils in GERD  
patients.1,18,19 Some authors determine the ‘cut-off  
value’ of eosinophil infiltration to differentiate EE and  
GERD. In EE, either in children or adults, some  
authors determines eosinophil infiltration of  
> 15 eosinophils/ HPF-high power field (400 x), or  
> 20 eosinophil/HPF or > 30 eosinophil/HPF on  
squamous epithelium. While in GERD, there is less than  
5 - 10 eosinophils/HPF. Other findings include positive  
eosinophils in the surface, which occasionally  
congregated and form a micro-abscess (i.e. 4 or more  
congregated eosinophils on the surface of esophagus  
epithelial). Micro-abscess is found in 25-45% of  
patients with EE, and it is never found in GERD 
patient.1,2,5,8,17  
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Table 2. Classification of esophagus disorder associated with eosinophil.3 
Primary eosinophilic 
esophagitis Secondary eosinophilic disorder Secondary noneosinophilic disorder 
(also known as idiopathic 
eosinophilic esophagitis and 
allergic esophagitis ) 
o atopic 
o Non-atopic 
o Familial 
o Eosinophilic gastroenteritis 
o Hyper-eosinophilic syndrome 
 
o Iatrogenic eosinophilic esophagus 
o Infectious associated EE 
o Primary gastroesophageal reflux 
o Esophageal leiomyomatosis 
o Vasculitis (periaarteritis nodosa) 
o Connective tissue disease (scleroderma) 
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Eosinophilic Esophagitis
CLASSIFICATION
Eosiphilic Esophagitis classification is very
confusing, one of its classifications is shown in table 2,
as follows:
TREATMENT
There is no established guideline for EE treatment.
The treatment may be classified into two categories,
i.e. (1) prevent or remove eosinophil stimulant and
(2) immune modulation.2
Diet and life-style modification
Diet and life-style modification is important in EE
treatment, especially is there is evidence of food
allergy. Allergy test may be performed as necessary.
Foods that frequently cause allergy include: milk, egg,
peanut, soybean, and fish. The patient may have
allergy test such as skin prick test and patch test or
aeroallergen test.2,7,12,20  Foods known as allergic cause
should be avoided. This diet modification is quite
effective for children but it is less effective in adult EE
case.2
Pharmacologic treatment
In addition to diet modification, pharmacologic
treatment of EE has been challenging, considering that,
there is no established study of EE pathophysiology
and there is no agreement reached in diagnostic
consensus.2,16
Either topical or systemic corticosteroid may be
given. Fluticasone is local corticosteroid, which was
given as 4 puffs of 220 ug, two times daily for 4 months
period.2,7
Side effect such as dry mouth may occur. There
was no oral candidiasis during the treatment.2,7
Systemic corticosteroid administered in the study
included methyl-predinisolone 1.5 mg/kg orally twice
daily for 4 weeks period, and subsequently tapped-off,
and stopped after  6 weeks. The patients experienced
clinical improvement with average improvement
period of 8 days. All patients had histological
improvement and decreased eosinophils amount and
IgE in peripheral blood count. After 1-year follow-up,
some patients had relapse. Some of them treated by
diet modification and the others were treated by
repeated corticosteroid treatment.2,7 Comparison
between topical corticosteroid and systemic
corticosteroid treatment is ongoing.2
Montelukast is a selective inhibitor against LTD4
(leukotriene D4). Patients with EE were given 10 mg
oral montelukast daily and then titrated to 100 mg daily,
with maintenance dose of 20-40 mg/day. There were
side effects of nausea and myalgia.2,7,21
Mepolizumab is a human monoclonal antibody, given
to patient with idiopathic hyper-eosinophilic syndrome
and EE who has no response to diet modification and
oral corticosteroid treatment. Three doses of
mepolizumab (10 mg/ kg IV) were administered with
4 weeks interval, and the patients were followed-up
for 18 weeks. There was obvious symptoms
improvement, There was also decreased peripheral
eosinophil. No adverse events were found. There is
no other study with larger number of participant has
been reported.2
Prognosis
Accurate diagnosis and corticosteroid treatment
(either topical or oral) combined with anti-reflux
treatment result clinical and histological improvement.
An 11-year observation of EE cases indicates no
serious complication. We need further evaluation to
investigate possibilities malignancies development of
EE.2
CONCLUSION
More EE cases has been reported, a consensus on
EE is extremely needed in order to reach the same
perception. In addition to esophageal symptoms,
esophageal biopsy in proximal and distal esophagus is
essential for establishing diagnosis of EE. Diet
modification is helpful. Topical or systemic
corticosteroid can be used. In adult EE, topical
corticosteroid appears to be more effective and
comfortable. Immunomodulator treatment is
promising. Combined therapy has not been explored.
We need larger study to confirm the efficacy of
treatment regimen.
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